Cargando…

Repurposing traditional immunomodulators to target the inflammatory burden of atherosclerosis()

Detalles Bibliográficos
Autores principales: Fender, Anke C., Dobrev, Dobromir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7214290/
https://www.ncbi.nlm.nih.gov/pubmed/32399483
http://dx.doi.org/10.1016/j.ijcha.2020.100535
_version_ 1783531936235388928
author Fender, Anke C.
Dobrev, Dobromir
author_facet Fender, Anke C.
Dobrev, Dobromir
author_sort Fender, Anke C.
collection PubMed
description
format Online
Article
Text
id pubmed-7214290
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-72142902020-05-12 Repurposing traditional immunomodulators to target the inflammatory burden of atherosclerosis() Fender, Anke C. Dobrev, Dobromir Int J Cardiol Heart Vasc Editorial Elsevier 2020-05-12 /pmc/articles/PMC7214290/ /pubmed/32399483 http://dx.doi.org/10.1016/j.ijcha.2020.100535 Text en © 2020 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Editorial
Fender, Anke C.
Dobrev, Dobromir
Repurposing traditional immunomodulators to target the inflammatory burden of atherosclerosis()
title Repurposing traditional immunomodulators to target the inflammatory burden of atherosclerosis()
title_full Repurposing traditional immunomodulators to target the inflammatory burden of atherosclerosis()
title_fullStr Repurposing traditional immunomodulators to target the inflammatory burden of atherosclerosis()
title_full_unstemmed Repurposing traditional immunomodulators to target the inflammatory burden of atherosclerosis()
title_short Repurposing traditional immunomodulators to target the inflammatory burden of atherosclerosis()
title_sort repurposing traditional immunomodulators to target the inflammatory burden of atherosclerosis()
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7214290/
https://www.ncbi.nlm.nih.gov/pubmed/32399483
http://dx.doi.org/10.1016/j.ijcha.2020.100535
work_keys_str_mv AT fenderankec repurposingtraditionalimmunomodulatorstotargettheinflammatoryburdenofatherosclerosis
AT dobrevdobromir repurposingtraditionalimmunomodulatorstotargettheinflammatoryburdenofatherosclerosis